Revaprazan
CAS: 199463-33-7
Ref. 3D-ZHA46333
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
Revaprazan
Synonyme:
- 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine
- YH 1885 free base
- 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-
- SB 641257
Beschreibung:
Revaprazan hydrochloride is the salt form of Revaprazan which is concentrated in the gastric parietal cell canaliculus. Due to the acidic environment of the parietal cells, Revaprazan is protonated and binds to and reversibly inhibits H+/K+-ATPase. As a result H+ ions are prevented from entering into the gastric lumen, thus hindering the production of gastric acid. This ability of Revaprazan has enabled it to be used to treat gastric ulcers and gastroesophageal reflux disease. According to the biopharmaceutical classification system, Revaprazan is a class II drug, however it has low oral bioavailability.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
362.4 g/mol
Formel:
C22H23FN4
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
